In this episode, we’re joined by Liz Powell, founder of Women’s Health Advocates. We discussed the organization’s policy priorities in the women’s health space. The post MedCity FemFwd: How Women’s Health Advocates Is Pushing for Change appeared first on MedCity News.
If HSAs and FSAs were functioning as originally intended, the rising out-of-pocket costs faced by most Americans would be met with increased financial fluency and agency. The post HSAs And FSAs Were Designed to Give Consumers Control and Clarity of Their Healthcare Spending — Why Isn’t This Happening? appeared first on MedCity News.
It’s a truth that many healthcare communicators overlook: the mental health crisis spans generations, yet the way people engage with mental health content is deeply shaped by age, experience and culture. The post Four Generations, One Conversation: Bridging the Mental Health Messaging Gap appeared first on MedCity News.
All of us can see glaring issues with the healthcare system that need to be addressed — but system-level change is hard. The leap to VBC isn’t easy, but the results are undeniable. The post Reclaiming the Joy of Medicine: How Value-Based Care Can Restore Physician Purpose appeared first on MedCity News.
By KIM BELLARD Over the years, one area of tech/health tech I have avoided writing about are brain-computer interfaces (B.C.I.). In part, it was because I thought they were kind of creepy, and, in larger part, because I was increasing finding Elon Musk, whose Neuralink is one of the leaders in the field, even more…
By KIM BELLARD Over the years, one area of tech/health tech I have avoided writing about are brain-computer interfaces (B.C.I.). In part, it was because I thought they were kind of creepy, and, in larger part, because I was increasing finding Elon Musk, whose Neuralink is one of the leaders in the field, even more…
The Pennsylvania-based company plans to open about a dozen sites annually for the foreseeable future to meet demand for environments away from hospital campus. The format also helps accommodate payer pressure.
That is the title of my new publication out today with the subtitle “A case study of rifaximin for the treatment of overt hepatic encephalopathy using QALY and non-QALY measures“. This was work with co-authors Shanshan Wang, Leonardo Passos Chaves, Olamide Olujohungbe, Sanjana Muthukrishnan, and Aditi Chaudhary. The abstract is below. BackgroundTraditional cost effectiveness analyses…
By MIKE MAGEE Give thanks for our America, blemishes and all. Ken Burns says as much, making it clear, we are a mess of contradictions, and that is (in part) what makes us a uniquely American. Consider that in a single week, we have had to endure Trump’s “Things happen” as he defended the Saudi…
Integra Community Care’s Ana Tuya Fulton, M.D., M.B.A., recently spoke about benefits of participating in West Health Learning and Action Network